CVC Technologies Inc.

TPEX:4744 Stock Report

Market Cap: NT$1.1b

CVC Technologies Valuation

Is 4744 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 4744 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 4744 (NT$19.45) is trading above our estimate of fair value (NT$1.71)

Significantly Below Fair Value: 4744 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 4744?

Key metric: As 4744 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 4744. This is calculated by dividing 4744's market cap by their current earnings.
What is 4744's PE Ratio?
PE Ratio93.8x
EarningsNT$11.41m
Market CapNT$1.07b

Price to Earnings Ratio vs Peers

How does 4744's PE Ratio compare to its peers?

The above table shows the PE ratio for 4744 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average17.4x
6730 Lagis Enterprise
16.5xn/aNT$1.2b
3184 MicroBase Technology
16.3xn/aNT$1.0b
4161 Bioptik Technology Incorporation
17.4xn/aNT$1.7b
6527 Crystalvue Medical
19.6xn/aNT$2.3b
4744 CVC Technologies
93.8xn/aNT$1.1b

Price-To-Earnings vs Peers: 4744 is expensive based on its Price-To-Earnings Ratio (93.8x) compared to the peer average (17.4x).

Price to Earnings Ratio vs Industry

How does 4744's PE Ratio compare vs other companies in the TW Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
4744 93.8xIndustry Avg. 19.7xNo. of Companies9PE01224364860+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 4744 is expensive based on its Price-To-Earnings Ratio (93.8x) compared to the TW Medical Equipment industry average (19.6x).

Price to Earnings Ratio vs Fair Ratio

What is 4744's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

4744 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio93.8x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 4744's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Universal Vision Biotechnology

NT$18.2b

Operates a chain of eye care clinics in Taiwan and China.

3218

NT$214.50

7D

3.6%

1Y

-27.3%

Hi-Clearance

NT$6.2b

Supplies medical devices for the renal, cardiac, radiation, dental, oral surgery, and metabolism markets in Taiwan.

1788

NT$139.00

7D

0.7%

1Y

2.6%

Pacific Hospital Supply

NT$6.5b

Manufactures, processes, and sells medical disposable products and equipment in Taiwan.

4126

NT$89.00

7D

0.2%

1Y

3.5%